Update on Myocarditis: From Etiology and Clinical Picture to Modern Diagnostics and Methods of Treatment
Diagnostics · 28.09.2023 · 13 (19) · 3073
DOI: 10.3390/diagnostics13193073 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diagnostics, online erschienen am 28.09.2023. Verfasst von Ratko Lasica und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Emergency Center, University Clinical Center of Serbia, 11000 Belgrade, Serbia. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 229 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Although the frequency of myocarditis in the general population is very difficult to accurately determine due to the large number of asymptomatic cases, the incidence of this disease is increasing significantly due to better defined criteria for diagnosis and the development of modern diagnostic methods. The multitude of different etiological factors, the diversity of the clinical picture, and the variability of the diagnostic findings make this disease often demanding both for the selection of the diagnostic modality and for the proper therapeutic approach. The previously known most common viral etiology of this disease is today overshadowed by new findings based on immune-mediated processes, associated with diseases that in their natural course can lead to myocardial involvement, as well as the iatrogenic cause of myocarditis, which is due to use of immune checkpoint inhibitors in the treatment of cancer patients. Suspecting that a patient with polymorphic and non-specific clinical signs and symptoms, such as changes in ECG and echocardiography readings, has myocarditis is the starting point in the diagnostic algorithm. Cardio magnetic resonance imaging is non-invasive and is the gold standard for diagnosis and clinical follow-up of these patients. Endomyocardial biopsy as an invasive method is the diagnostic choice in life-threatening cases with suspicion of fulminant myocarditis where the diagnosis has not yet established or there is no adequate response to the applied therapeutic regimen. The treatment of myocarditis is increasingly demanding and includes conservative methods of treating heart failure, immunomodulatory and immunospressive therapy, methods of mechanical circulatory support, and heart transplantation. The goal of developing new diagnostic and therapeutic methods is to reduce mortality from this complex disease, which is still high.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Emergency Center, University Clinical Center of Serbia, 11000 Belgrade, Serbia.
- Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
- Department of Cardiology, University Medical Center Bezanijska Kosa, 11000 Belgrade, Serbia.
- Department of Cardiology, University Clinical Center of Serbia, 11000 Belgrade, Serbia.
- Health Center New Belgrade, 11000 Belgrade, Serbia.
ORCID-Profile: Ratko Lasica, Lazar Djukanovic, Lidija Savic, Marija Zdravkovic
Zitieren
APA
Lasica, R., Djukanovic, L., Savic, L., Krljanac, G., Zdravkovic, M., Ristic, M., Lasica, A., Asanin, M., & Ristic, A. (2023). Update on Myocarditis: From Etiology and Clinical Picture to Modern Diagnostics and Methods of Treatment. Diagnostics, 13(19), 3073. https://doi.org/10.3390/diagnostics13193073
Vancouver
Lasica R, Djukanovic L, Savic L, Krljanac G, Zdravkovic M, Ristic M, et al. Update on Myocarditis: From Etiology and Clinical Picture to Modern Diagnostics and Methods of Treatment. Diagnostics. 2023;13(19):3073. doi:10.3390/diagnostics13193073
BibTeX
@article{Lasica2023,
author = {Lasica, Ratko and Djukanovic, Lazar and Savic, Lidija and Krljanac, Gordana and Zdravkovic, Marija and Ristic, Marko and Lasica, Andjelka and Asanin, Milika and Ristic, Arsen},
title = {Update on Myocarditis: From Etiology and Clinical Picture to Modern Diagnostics and Methods of Treatment},
journal = {Diagnostics},
year = {2023},
volume = {13},
number = {19},
pages = {3073},
doi = {10.3390/diagnostics13193073}
}
EUVIMED